RKLB
Wall Street’s new space crush
Rocket Lab is having one of those days where the chart looks like it drank three cold brews. Needham raised its price target to $120 from $95 and kept the Buy rating intact, basically saying, “Yep, the space story still has legs.”
The timing matters because the analyst didn’t just wave a hand and say “vibes are good.” The note leaned on Rocket Lab’s stronger-than-expected first quarter, rising backlog, and progress on Neutron — the bigger rocket that’s supposed to help the company level up from scrappy underdog to serious launch contender.
Why investors are paying attention
The company posted Q1 revenue of $200.4 million, which topped expectations and jumped 63% year over year. Needham also pointed to:
- backlog climbing to $2.2 billion
- a five-launch Neutron contract running through 2029
- three more Electron launches
- a $30 million Anduril deal tied to HASTE hypersonic missions
That’s the kind of pipeline that makes investors stop squinting at the present and start daydreaming about the future.
The Neutron-sized bet
The real story here is Neutron. Needham says the test launch is still on track for the fourth quarter of 2026, and if that goes well, it could be a huge unlock for margin and cash flow. Translation: fewer “cool space company” jokes, more “actual business with leverage” energy.
Of course, this is still a space company, which means delays, budget surprises, and competition are never far away. Needham’s bear case includes Neutron slippage, lost contracts, price pressure, and the ever-fun possibility of needing more capital down the road.
Big picture: Rocket Lab is still in the proving-it phase, but Wall Street just handed it a louder microphone.